Hualan Biological Engineering
Establishment time : 1992
website : www.hualanbio.com
Main Product : vaccines, blood products, diagnostic reagents
Company Profile
Hualan Biological Engineering is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. With a history dating back to 1992, the company has grown to over 3,000 employees and has established a strong presence in markets across China, Asia, Africa, and Latin America. Hualan Biological Engineering is known for its high-quality products and is considered a key player in the biopharmaceutical industry in China.
Chengdu Institute of Biological Products
Establishment time : 1967
website : http://www.cibp.cnbio.cn/
Main Product : vaccines, biological products
Company Profile
Chengdu Institute of Biological Products is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines and biological products. Established in 1967, the company has grown to become a key player in the healthcare industry, serving both domestic and international markets with high-quality and innovative products. With a large production capacity and a strong reputation for excellence, Chengdu Institute of Biological Products continues to lead the way in the field of biopharmaceuticals.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Sinovac Biotech
Establishment time : Sinovac Biotech is a leading biopharmaceutical company based in China.
website :
Main Product : Sinovac is known for its expertise in developing vaccines for infectious diseases.
Company Profile
With a dedicated team of scientists and researchers, Sinovac continues to make significant contributions to the field of vaccinology.
Wuhan Institute of Biological Products
Establishment time : Wuhan Institute of Biological Products (WIBP) was established in 1965 and is a leading biopharmaceutical company in China.
website :
Main Product : With a medium-sized workforce, WIBP has a strong presence in the Chinese market and also exports its products to international markets.
Company Profile
Overall, Wuhan Institute of Biological Products is a reputable company with a long history of contributing to the healthcare industry through its innovative vaccine products.
Changchun Institute of Biological Products
Establishment time : Changchun Institute of Biological Products (CIBP) was established in 1941 and has since become a leading producer of vaccines and blood products in China.
website :
Main Product : With a large company size, CIBP has a strong presence in the Chinese and Asian markets.
Company Profile
Overall, Changchun Institute of Biological Products is a reputable and reliable company that is dedicated to improving public health through its high-quality products and services.
July 06, 2024
